Abstract
During a 28-year period, 949 patients were treated for adenocarcinoma of the endometrium at the University of Minnesota Hospitals. Eighty-one of these patients presented with vaginal recurrence. The incidence of vaginal recurrence for patients receiving primary therapy at this institution was 0.9%. Sixty-nine percent of patients presented with vaginal bleeding, but 22% were asymptomatic. Seventy-three percent of patients eventually died of disease. Seventy-five percent of recurrences occurred within 3 years of primary therapy, but much longer intervals were noted. In patients with isolated vaginal recurrences, the interval to recurrence directly correlated with survival (P < 0.0005). The poor outcome of these patients indicates a need for evaluation of adjuvant therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 323-328 |
| Number of pages | 6 |
| Journal | Gynecologic Oncology |
| Volume | 13 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 1982 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Oncology
Cite this
Vaginal recurrence of adenocarcinoma of the endometrium. / Phillips, George L.; Prem, Konald A.; Adcock, Leon L.; Twiggs, Leo B.
In: Gynecologic Oncology, Vol. 13, No. 3, 01.01.1982, p. 323-328.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Vaginal recurrence of adenocarcinoma of the endometrium
AU - Phillips, George L.
AU - Prem, Konald A.
AU - Adcock, Leon L.
AU - Twiggs, Leo B.
PY - 1982/1/1
Y1 - 1982/1/1
N2 - During a 28-year period, 949 patients were treated for adenocarcinoma of the endometrium at the University of Minnesota Hospitals. Eighty-one of these patients presented with vaginal recurrence. The incidence of vaginal recurrence for patients receiving primary therapy at this institution was 0.9%. Sixty-nine percent of patients presented with vaginal bleeding, but 22% were asymptomatic. Seventy-three percent of patients eventually died of disease. Seventy-five percent of recurrences occurred within 3 years of primary therapy, but much longer intervals were noted. In patients with isolated vaginal recurrences, the interval to recurrence directly correlated with survival (P < 0.0005). The poor outcome of these patients indicates a need for evaluation of adjuvant therapy.
AB - During a 28-year period, 949 patients were treated for adenocarcinoma of the endometrium at the University of Minnesota Hospitals. Eighty-one of these patients presented with vaginal recurrence. The incidence of vaginal recurrence for patients receiving primary therapy at this institution was 0.9%. Sixty-nine percent of patients presented with vaginal bleeding, but 22% were asymptomatic. Seventy-three percent of patients eventually died of disease. Seventy-five percent of recurrences occurred within 3 years of primary therapy, but much longer intervals were noted. In patients with isolated vaginal recurrences, the interval to recurrence directly correlated with survival (P < 0.0005). The poor outcome of these patients indicates a need for evaluation of adjuvant therapy.
UR - http://www.scopus.com/inward/record.url?scp=0019980844&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019980844&partnerID=8YFLogxK
U2 - 10.1016/0090-8258(82)90070-1
DO - 10.1016/0090-8258(82)90070-1
M3 - Article
C2 - 7095571
AN - SCOPUS:0019980844
VL - 13
SP - 323
EP - 328
JO - Gynecologic Oncology
JF - Gynecologic Oncology
SN - 0090-8258
IS - 3
ER -